NCT01103011View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
Parkinson's Disease
Interventions
DRUG

ND0611

Continuous delivery of ND0611

DRUG

ND0611

Solution of ND0611 delivered continuously

Trial Locations (1)

Unknown

Hadassah Medical Center, Jerusalem

Sponsors

Lead Sponsor

NeuroDerm Ltd.
All Listed Sponsors
lead

NeuroDerm Ltd.

INDUSTRY

NCT01103011 - Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611 | Biotech Hunter | Biotech Hunter